Cargando…
Normal and Pathological NRF2 Signalling in the Central Nervous System
The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394413/ https://www.ncbi.nlm.nih.gov/pubmed/35892629 http://dx.doi.org/10.3390/antiox11081426 |
_version_ | 1784771484567207936 |
---|---|
author | Heurtaux, Tony Bouvier, David S. Benani, Alexandre Helgueta Romero, Sergio Frauenknecht, Katrin B. M. Mittelbronn, Michel Sinkkonen, Lasse |
author_facet | Heurtaux, Tony Bouvier, David S. Benani, Alexandre Helgueta Romero, Sergio Frauenknecht, Katrin B. M. Mittelbronn, Michel Sinkkonen, Lasse |
author_sort | Heurtaux, Tony |
collection | PubMed |
description | The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation, immunity, and differentiation have been attributed to this pleiotropic transcription factor that regulates hundreds of genes. After 40 years of in-depth research and key discoveries, NRF2 is now at the center of a vast regulatory network, revealing NRF2 signalling as increasingly complex. It is widely recognized that reactive oxygen species (ROS) play a key role in human physiological and pathological processes such as ageing, obesity, diabetes, cancer, and neurodegenerative diseases. The high oxygen consumption associated with high levels of free iron and oxidizable unsaturated lipids make the brain particularly vulnerable to oxidative stress. A good stability of NRF2 activity is thus crucial to maintain the redox balance and therefore brain homeostasis. In this review, we have gathered recent data about the contribution of the NRF2 pathway in the healthy brain as well as during metabolic diseases, cancer, ageing, and ageing-related neurodegenerative diseases. We also discuss promising therapeutic strategies and the need for better understanding of cell-type-specific functions of NRF2 in these different fields. |
format | Online Article Text |
id | pubmed-9394413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93944132022-08-23 Normal and Pathological NRF2 Signalling in the Central Nervous System Heurtaux, Tony Bouvier, David S. Benani, Alexandre Helgueta Romero, Sergio Frauenknecht, Katrin B. M. Mittelbronn, Michel Sinkkonen, Lasse Antioxidants (Basel) Review The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation, immunity, and differentiation have been attributed to this pleiotropic transcription factor that regulates hundreds of genes. After 40 years of in-depth research and key discoveries, NRF2 is now at the center of a vast regulatory network, revealing NRF2 signalling as increasingly complex. It is widely recognized that reactive oxygen species (ROS) play a key role in human physiological and pathological processes such as ageing, obesity, diabetes, cancer, and neurodegenerative diseases. The high oxygen consumption associated with high levels of free iron and oxidizable unsaturated lipids make the brain particularly vulnerable to oxidative stress. A good stability of NRF2 activity is thus crucial to maintain the redox balance and therefore brain homeostasis. In this review, we have gathered recent data about the contribution of the NRF2 pathway in the healthy brain as well as during metabolic diseases, cancer, ageing, and ageing-related neurodegenerative diseases. We also discuss promising therapeutic strategies and the need for better understanding of cell-type-specific functions of NRF2 in these different fields. MDPI 2022-07-22 /pmc/articles/PMC9394413/ /pubmed/35892629 http://dx.doi.org/10.3390/antiox11081426 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Heurtaux, Tony Bouvier, David S. Benani, Alexandre Helgueta Romero, Sergio Frauenknecht, Katrin B. M. Mittelbronn, Michel Sinkkonen, Lasse Normal and Pathological NRF2 Signalling in the Central Nervous System |
title | Normal and Pathological NRF2 Signalling in the Central Nervous System |
title_full | Normal and Pathological NRF2 Signalling in the Central Nervous System |
title_fullStr | Normal and Pathological NRF2 Signalling in the Central Nervous System |
title_full_unstemmed | Normal and Pathological NRF2 Signalling in the Central Nervous System |
title_short | Normal and Pathological NRF2 Signalling in the Central Nervous System |
title_sort | normal and pathological nrf2 signalling in the central nervous system |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394413/ https://www.ncbi.nlm.nih.gov/pubmed/35892629 http://dx.doi.org/10.3390/antiox11081426 |
work_keys_str_mv | AT heurtauxtony normalandpathologicalnrf2signallinginthecentralnervoussystem AT bouvierdavids normalandpathologicalnrf2signallinginthecentralnervoussystem AT benanialexandre normalandpathologicalnrf2signallinginthecentralnervoussystem AT helguetaromerosergio normalandpathologicalnrf2signallinginthecentralnervoussystem AT frauenknechtkatrinbm normalandpathologicalnrf2signallinginthecentralnervoussystem AT mittelbronnmichel normalandpathologicalnrf2signallinginthecentralnervoussystem AT sinkkonenlasse normalandpathologicalnrf2signallinginthecentralnervoussystem |